The thesis explains that Chittodvega represents a minor psychic disorder with multiple somatic manifestations caused by an overactivation of Rajah and Tamas. This mental imbalance directly vitiates the Manovaha Srotas and disrupts physical Dosha, predominantly aggravating Prana, Udana, and Vyana Vayu, along with Sadhaka Pitta and Tarpaka Kapha. The statistical analysis derived from the clinical observations safely rejects the null hypothesis. The data confirms that the combined therapeutic regimen yields a statistically highly significant improvement (P < 0.001) in relieving both the psychic and somatic manifestations of anxiety.

The pharmacological action of Medhya Rasayana addresses this pathology directly: Mandukparni active saponins target the muscarinic acetylcholine receptor M1 to enhance memory; Shankhpushpi bio-chemicals interact with neuro-synapses to increase serotonin concentration; Ashwagandha steroidal lactones regulate the HPA axis to counter nervous exhaustion; Shatavari reduces brain MAO-A and MAO-B levels to exert antidepressant actions; and Yashtimadhu protects central neurons from oxidative stress.

The addition of Shavasana serves as a crucial somatic intervention. By inducing conscious stillness, it shifts autonomic tone from sympathetic dominance to parasympathetic compliance, relaxes overactive muscle contraction within the Mamsavaha Srotas, and clears background mental stress. This explains the marked superiority of Group B in eliminating chronic fatigue, reducing physical muscle rigidity, and restoring natural sleep architecture.

Based on the overall clinical, psychological, and statistical findings of the present study, it can be concluded that both Medhya Rasayana alone and Medhya Rasayana combined with Shavasana are safe and effective interventions for the management of anxiety disorder.